HCW Biologics Stock Set to Reverse Split on Friday, April 11th (NASDAQ:HCWB)

HCW Biologics Inc. (NASDAQ:HCWB) shares are going to reverse split before the market opens on Friday, April 11th. The 1-40 reverse split was announced on Tuesday, April 1st. The number of shares owned by shareholders will be adjusted after the closing bell on Thursday, April 10th.

HCW Biologics Stock Up 0.3 %

NASDAQ HCWB opened at $0.28 on Thursday. HCW Biologics has a fifty-two week low of $0.21 and a fifty-two week high of $2.52. The business has a 50 day moving average price of $0.36 and a two-hundred day moving average price of $0.44. The stock has a market cap of $12.55 million, a PE ratio of -0.28 and a beta of 0.71.

HCW Biologics (NASDAQ:HCWB) last posted its earnings results on Friday, March 28th. The company reported ($0.08) EPS for the quarter. The firm had revenue of $0.40 million for the quarter. HCW Biologics had a negative return on equity of 2,516.84% and a negative net margin of 1,067.82%.

About HCW Biologics

HCW Biologics Inc, a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases.